Stannanecarbonitrile,tributyl-
Product Information
Molecular Formula
C13H27 N Sn
Molecular Weight
316.10
Description
Stannanecarbonitrile, tributyl- is an indispensable entity within the biomedical realm. With its wide-ranging application potential, this compound emerges as a pivotal tool in the remediation of diverse afflictions encompassing cancer, cardiovascular disorders, and inflammatory states. Leveraging its extraordinary chemical characteristics, it assumes a paramount role in the creation of pharmacological agents with curative attributes targeting these pathological conditions.
Synonyms
tributylcyano-ti; tributylcyanotin; tributyl-stannanecarbonitril; TRIBUTYLTIN CYANIDE; TRI-N-BUTYLTIN CYANIDE; TRI-N-BUTYLCYANOTIN; (Tributylstannyl) cyanide; Cyanotributylstannane
IUPAC Name
tributylstannylformonitrile
SMILES
CCCC[Sn](CCCC)(CCCC)C#N
InChI
InChI=1S/3C4H9.CN.Sn/c3*1-3-4-21-2/h3*1,3-4H2,2H3
InChI Key
GMYAQHAKWKXYHG-UHFFFAOYSA-N
Melting Point
105-107 °C (lit.)
Flash Point
Not applicable
Purity
97%
Safety Information
Hazards
H301 + H311 + H331 - H315 - H319 - H335 - H412
Precautionary Statement
P273 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311 - P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
1
Rotatable Bond Count
9
Exact Mass
317.116552 g/mol
Monoisotopic Mass
317.116552 g/mol
Topological Polar Surface Area
23.8Ų
Heavy Atom Count
15
Formal Charge
0
Complexity
170
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| US-2021309689-A1 | Methods of preparing 1'-cyano nucleosides | 2020-03-12 |
| WO-2021183750-A2 | Methods of preparing 1'-cyano nucleosides | 2020-03-12 |
| CN-111748550-A | Method for labeling nucleic acid | 2019-03-29 |
| EP-3715469-A1 | Labeling method for nucleic acid | 2019-03-29 |
| JP-2020162476-A | Nucleic acid labeling method | 2019-03-29 |
| KR-20200115113-A | Labelling method for nucleic acid | 2019-03-29 |
| US-2020308635-A1 | Labeling method for nucleic acid | 2019-03-29 |
| EP-3715469-B1 | Labeling method for nucleic acid | 2019-03-29 |
| JP-6960639-B2 | Nucleic acid labeling method | 2019-03-29 |
| JP-2019073507-A | Drugs containing prodrugs of amino acid derivatives | 2017-10-17 |
